Files in This Item:


Title: Regional production of oseltamivir: review of the current situation
Other Titles: report of an informal meeting, New Delhi, India, 30-31 March 2006
Authors: World Health Organization, Regional Office for South-East Asia
Issue Date: 2006
Publisher: WHO Regional Office for South-East Asia
Place of publication: New Delhi
Language: English
Abstract: Oseltamivir is currently seen as the most efficacious drug which can be taken orally for treatment of human avian influenza. Since avian influenza has become endemic in poultry in some countries of Asia, there is a constant threat of human infection. It is therefore important to have adequate stockpiles of antiviral at both regional and national levels. Against this background, a meeting was organized to discuss the prospects of regional production of oseltamivir as part of pandemic preparedness and response. Fortunately, the Region has many pharmaceutical companies which can manufacture the drug, thus increasing the likelihood of its availability. What needs to be done is to foster and strengthen partnerships, i.e. public-private partnerships. WHO will have to take the lead for regional stockpiling and implement the guidelines for stockpiling of oseltamivir at the regional level.
Gov't Doc #: SEA-CD-152
Appears in Collections:Meeting Reports

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.